Request for Covid-19 Impact Assessment of this Report
The United States Aurora Kinase B market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Aurora Kinase B market, reaching US$ million by the year 2028. As for the Europe Aurora Kinase B landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Aurora Kinase B players cover AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, and Amgen Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Aurora Kinase B market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
AZD-2811
CS-2164
Danusertib
Ilorasertib
NMI-900
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Anaplastic Large Cell Lymphoma
Kidney Cancer
Lung Cancer
Prostate Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie Inc
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
AstraZeneca Plc
Chipscreen Biosciences Ltd
Cielo Therapeutics Inc
Sanofi
Sareum Holdings Plc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aurora Kinase B Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Aurora Kinase B by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Aurora Kinase B by Country/Region, 2017, 2022 & 2028
2.2 Aurora Kinase B Segment by Type
2.2.1 AZD-2811
2.2.2 CS-2164
2.2.3 Danusertib
2.2.4 Ilorasertib
2.2.5 NMI-900
2.2.6 Others
2.3 Aurora Kinase B Sales by Type
2.3.1 Global Aurora Kinase B Sales Market Share by Type (2017-2022)
2.3.2 Global Aurora Kinase B Revenue and Market Share by Type (2017-2022)
2.3.3 Global Aurora Kinase B Sale Price by Type (2017-2022)
2.4 Aurora Kinase B Segment by Application
2.4.1 Anaplastic Large Cell Lymphoma
2.4.2 Kidney Cancer
2.4.3 Lung Cancer
2.4.4 Prostate Cancer
2.4.5 Others
2.5 Aurora Kinase B Sales by Application
2.5.1 Global Aurora Kinase B Sale Market Share by Application (2017-2022)
2.5.2 Global Aurora Kinase B Revenue and Market Share by Application (2017-2022)
2.5.3 Global Aurora Kinase B Sale Price by Application (2017-2022)
3 Global Aurora Kinase B by Company
3.1 Global Aurora Kinase B Breakdown Data by Company
3.1.1 Global Aurora Kinase B Annual Sales by Company (2020-2022)
3.1.2 Global Aurora Kinase B Sales Market Share by Company (2020-2022)
3.2 Global Aurora Kinase B Annual Revenue by Company (2020-2022)
3.2.1 Global Aurora Kinase B Revenue by Company (2020-2022)
3.2.2 Global Aurora Kinase B Revenue Market Share by Company (2020-2022)
3.3 Global Aurora Kinase B Sale Price by Company
3.4 Key Manufacturers Aurora Kinase B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aurora Kinase B Product Location Distribution
3.4.2 Players Aurora Kinase B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aurora Kinase B by Geographic Region
4.1 World Historic Aurora Kinase B Market Size by Geographic Region (2017-2022)
4.1.1 Global Aurora Kinase B Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Aurora Kinase B Annual Revenue by Geographic Region
4.2 World Historic Aurora Kinase B Market Size by Country/Region (2017-2022)
4.2.1 Global Aurora Kinase B Annual Sales by Country/Region (2017-2022)
4.2.2 Global Aurora Kinase B Annual Revenue by Country/Region
4.3 Americas Aurora Kinase B Sales Growth
4.4 APAC Aurora Kinase B Sales Growth
4.5 Europe Aurora Kinase B Sales Growth
4.6 Middle East & Africa Aurora Kinase B Sales Growth
5 Americas
5.1 Americas Aurora Kinase B Sales by Country
5.1.1 Americas Aurora Kinase B Sales by Country (2017-2022)
5.1.2 Americas Aurora Kinase B Revenue by Country (2017-2022)
5.2 Americas Aurora Kinase B Sales by Type
5.3 Americas Aurora Kinase B Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aurora Kinase B Sales by Region
6.1.1 APAC Aurora Kinase B Sales by Region (2017-2022)
6.1.2 APAC Aurora Kinase B Revenue by Region (2017-2022)
6.2 APAC Aurora Kinase B Sales by Type
6.3 APAC Aurora Kinase B Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aurora Kinase B by Country
7.1.1 Europe Aurora Kinase B Sales by Country (2017-2022)
7.1.2 Europe Aurora Kinase B Revenue by Country (2017-2022)
7.2 Europe Aurora Kinase B Sales by Type
7.3 Europe Aurora Kinase B Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aurora Kinase B by Country
8.1.1 Middle East & Africa Aurora Kinase B Sales by Country (2017-2022)
8.1.2 Middle East & Africa Aurora Kinase B Revenue by Country (2017-2022)
8.2 Middle East & Africa Aurora Kinase B Sales by Type
8.3 Middle East & Africa Aurora Kinase B Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aurora Kinase B
10.3 Manufacturing Process Analysis of Aurora Kinase B
10.4 Industry Chain Structure of Aurora Kinase B
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aurora Kinase B Distributors
11.3 Aurora Kinase B Customer
12 World Forecast Review for Aurora Kinase B by Geographic Region
12.1 Global Aurora Kinase B Market Size Forecast by Region
12.1.1 Global Aurora Kinase B Forecast by Region (2023-2028)
12.1.2 Global Aurora Kinase B Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aurora Kinase B Forecast by Type
12.7 Global Aurora Kinase B Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc
13.1.1 AbbVie Inc Company Information
13.1.2 AbbVie Inc Aurora Kinase B Product Offered
13.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Inc Main Business Overview
13.1.5 AbbVie Inc Latest Developments
13.2 Advenchen Laboratories LLC
13.2.1 Advenchen Laboratories LLC Company Information
13.2.2 Advenchen Laboratories LLC Aurora Kinase B Product Offered
13.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Advenchen Laboratories LLC Main Business Overview
13.2.5 Advenchen Laboratories LLC Latest Developments
13.3 Aeterna Zentaris Inc
13.3.1 Aeterna Zentaris Inc Company Information
13.3.2 Aeterna Zentaris Inc Aurora Kinase B Product Offered
13.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Aeterna Zentaris Inc Main Business Overview
13.3.5 Aeterna Zentaris Inc Latest Developments
13.4 Amgen Inc
13.4.1 Amgen Inc Company Information
13.4.2 Amgen Inc Aurora Kinase B Product Offered
13.4.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Amgen Inc Main Business Overview
13.4.5 Amgen Inc Latest Developments
13.5 AstraZeneca Plc
13.5.1 AstraZeneca Plc Company Information
13.5.2 AstraZeneca Plc Aurora Kinase B Product Offered
13.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Plc Main Business Overview
13.5.5 AstraZeneca Plc Latest Developments
13.6 Chipscreen Biosciences Ltd
13.6.1 Chipscreen Biosciences Ltd Company Information
13.6.2 Chipscreen Biosciences Ltd Aurora Kinase B Product Offered
13.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Chipscreen Biosciences Ltd Main Business Overview
13.6.5 Chipscreen Biosciences Ltd Latest Developments
13.7 Cielo Therapeutics Inc
13.7.1 Cielo Therapeutics Inc Company Information
13.7.2 Cielo Therapeutics Inc Aurora Kinase B Product Offered
13.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Cielo Therapeutics Inc Main Business Overview
13.7.5 Cielo Therapeutics Inc Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Aurora Kinase B Product Offered
13.8.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Sareum Holdings Plc
13.9.1 Sareum Holdings Plc Company Information
13.9.2 Sareum Holdings Plc Aurora Kinase B Product Offered
13.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sareum Holdings Plc Main Business Overview
13.9.5 Sareum Holdings Plc Latest Developments
14 Research Findings and Conclusion
Table 1. Aurora Kinase B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Aurora Kinase B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AZD-2811
Table 4. Major Players of CS-2164
Table 5. Major Players of Danusertib
Table 6. Major Players of Ilorasertib
Table 7. Major Players of NMI-900
Table 8. Major Players of Others
Table 9. Global Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)
Table 10. Global Aurora Kinase B Sales Market Share by Type (2017-2022)
Table 11. Global Aurora Kinase B Revenue by Type (2017-2022) & ($ million)
Table 12. Global Aurora Kinase B Revenue Market Share by Type (2017-2022)
Table 13. Global Aurora Kinase B Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)
Table 15. Global Aurora Kinase B Sales Market Share by Application (2017-2022)
Table 16. Global Aurora Kinase B Revenue by Application (2017-2022)
Table 17. Global Aurora Kinase B Revenue Market Share by Application (2017-2022)
Table 18. Global Aurora Kinase B Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global Aurora Kinase B Sales by Company (2020-2022) & (K Pcs)
Table 20. Global Aurora Kinase B Sales Market Share by Company (2020-2022)
Table 21. Global Aurora Kinase B Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Aurora Kinase B Revenue Market Share by Company (2020-2022)
Table 23. Global Aurora Kinase B Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers Aurora Kinase B Producing Area Distribution and Sales Area
Table 25. Players Aurora Kinase B Products Offered
Table 26. Aurora Kinase B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Aurora Kinase B Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global Aurora Kinase B Sales Market Share Geographic Region (2017-2022)
Table 31. Global Aurora Kinase B Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Aurora Kinase B Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Aurora Kinase B Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global Aurora Kinase B Sales Market Share by Country/Region (2017-2022)
Table 35. Global Aurora Kinase B Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Aurora Kinase B Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Aurora Kinase B Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas Aurora Kinase B Sales Market Share by Country (2017-2022)
Table 39. Americas Aurora Kinase B Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Aurora Kinase B Revenue Market Share by Country (2017-2022)
Table 41. Americas Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas Aurora Kinase B Sales Market Share by Type (2017-2022)
Table 43. Americas Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas Aurora Kinase B Sales Market Share by Application (2017-2022)
Table 45. APAC Aurora Kinase B Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC Aurora Kinase B Sales Market Share by Region (2017-2022)
Table 47. APAC Aurora Kinase B Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Aurora Kinase B Revenue Market Share by Region (2017-2022)
Table 49. APAC Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC Aurora Kinase B Sales Market Share by Type (2017-2022)
Table 51. APAC Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC Aurora Kinase B Sales Market Share by Application (2017-2022)
Table 53. Europe Aurora Kinase B Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe Aurora Kinase B Sales Market Share by Country (2017-2022)
Table 55. Europe Aurora Kinase B Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Aurora Kinase B Revenue Market Share by Country (2017-2022)
Table 57. Europe Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Aurora Kinase B Sales Market Share by Type (2017-2022)
Table 59. Europe Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe Aurora Kinase B Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Aurora Kinase B Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Aurora Kinase B Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Aurora Kinase B Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Aurora Kinase B Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Aurora Kinase B Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Aurora Kinase B Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Aurora Kinase B Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Aurora Kinase B Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Aurora Kinase B
Table 70. Key Market Challenges & Risks of Aurora Kinase B
Table 71. Key Industry Trends of Aurora Kinase B
Table 72. Aurora Kinase B Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Aurora Kinase B Distributors List
Table 75. Aurora Kinase B Customer List
Table 76. Global Aurora Kinase B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global Aurora Kinase B Sales Market Forecast by Region
Table 78. Global Aurora Kinase B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Aurora Kinase B Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Aurora Kinase B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas Aurora Kinase B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Aurora Kinase B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC Aurora Kinase B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Aurora Kinase B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe Aurora Kinase B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Aurora Kinase B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa Aurora Kinase B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Aurora Kinase B Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global Aurora Kinase B Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Aurora Kinase B Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Aurora Kinase B Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Aurora Kinase B Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global Aurora Kinase B Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Aurora Kinase B Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Aurora Kinase B Revenue Market Share Forecast by Application (2023-2028)
Table 96. AbbVie Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 97. AbbVie Inc Aurora Kinase B Product Offered
Table 98. AbbVie Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. AbbVie Inc Main Business
Table 100. AbbVie Inc Latest Developments
Table 101. Advenchen Laboratories LLC Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 102. Advenchen Laboratories LLC Aurora Kinase B Product Offered
Table 103. Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. Advenchen Laboratories LLC Main Business
Table 105. Advenchen Laboratories LLC Latest Developments
Table 106. Aeterna Zentaris Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 107. Aeterna Zentaris Inc Aurora Kinase B Product Offered
Table 108. Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Aeterna Zentaris Inc Main Business
Table 110. Aeterna Zentaris Inc Latest Developments
Table 111. Amgen Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 112. Amgen Inc Aurora Kinase B Product Offered
Table 113. Amgen Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Amgen Inc Main Business
Table 115. Amgen Inc Latest Developments
Table 116. AstraZeneca Plc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Plc Aurora Kinase B Product Offered
Table 118. AstraZeneca Plc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. AstraZeneca Plc Main Business
Table 120. AstraZeneca Plc Latest Developments
Table 121. Chipscreen Biosciences Ltd Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 122. Chipscreen Biosciences Ltd Aurora Kinase B Product Offered
Table 123. Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Chipscreen Biosciences Ltd Main Business
Table 125. Chipscreen Biosciences Ltd Latest Developments
Table 126. Cielo Therapeutics Inc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 127. Cielo Therapeutics Inc Aurora Kinase B Product Offered
Table 128. Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. Cielo Therapeutics Inc Main Business
Table 130. Cielo Therapeutics Inc Latest Developments
Table 131. Sanofi Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 132. Sanofi Aurora Kinase B Product Offered
Table 133. Sanofi Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. Sanofi Main Business
Table 135. Sanofi Latest Developments
Table 136. Sareum Holdings Plc Basic Information, Aurora Kinase B Manufacturing Base, Sales Area and Its Competitors
Table 137. Sareum Holdings Plc Aurora Kinase B Product Offered
Table 138. Sareum Holdings Plc Aurora Kinase B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 139. Sareum Holdings Plc Main Business
Table 140. Sareum Holdings Plc Latest Developments
List of Figures
Figure 1. Picture of Aurora Kinase B
Figure 2. Aurora Kinase B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aurora Kinase B Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Aurora Kinase B Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Aurora Kinase B Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AZD-2811
Figure 10. Product Picture of CS-2164
Figure 11. Product Picture of Danusertib
Figure 12. Product Picture of Ilorasertib
Figure 13. Product Picture of NMI-900
Figure 14. Product Picture of Others
Figure 15. Global Aurora Kinase B Sales Market Share by Type in 2021
Figure 16. Global Aurora Kinase B Revenue Market Share by Type (2017-2022)
Figure 17. Aurora Kinase B Consumed in Anaplastic Large Cell Lymphoma
Figure 18. Global Aurora Kinase B Market: Anaplastic Large Cell Lymphoma (2017-2022) & (K Pcs)
Figure 19. Aurora Kinase B Consumed in Kidney Cancer
Figure 20. Global Aurora Kinase B Market: Kidney Cancer (2017-2022) & (K Pcs)
Figure 21. Aurora Kinase B Consumed in Lung Cancer
Figure 22. Global Aurora Kinase B Market: Lung Cancer (2017-2022) & (K Pcs)
Figure 23. Aurora Kinase B Consumed in Prostate Cancer
Figure 24. Global Aurora Kinase B Market: Prostate Cancer (2017-2022) & (K Pcs)
Figure 25. Aurora Kinase B Consumed in Others
Figure 26. Global Aurora Kinase B Market: Others (2017-2022) & (K Pcs)
Figure 27. Global Aurora Kinase B Sales Market Share by Application (2017-2022)
Figure 28. Global Aurora Kinase B Revenue Market Share by Application in 2021
Figure 29. Aurora Kinase B Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Aurora Kinase B Revenue Market Share by Company in 2021
Figure 31. Global Aurora Kinase B Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Aurora Kinase B Revenue Market Share by Geographic Region in 2021
Figure 33. Global Aurora Kinase B Sales Market Share by Region (2017-2022)
Figure 34. Global Aurora Kinase B Revenue Market Share by Country/Region in 2021
Figure 35. Americas Aurora Kinase B Sales 2017-2022 (K Pcs)
Figure 36. Americas Aurora Kinase B Revenue 2017-2022 ($ Millions)
Figure 37. APAC Aurora Kinase B Sales 2017-2022 (K Pcs)
Figure 38. APAC Aurora Kinase B Revenue 2017-2022 ($ Millions)
Figure 39. Europe Aurora Kinase B Sales 2017-2022 (K Pcs)
Figure 40. Europe Aurora Kinase B Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Aurora Kinase B Sales 2017-2022 (K Pcs)
Figure 42. Middle East & Africa Aurora Kinase B Revenue 2017-2022 ($ Millions)
Figure 43. Americas Aurora Kinase B Sales Market Share by Country in 2021
Figure 44. Americas Aurora Kinase B Revenue Market Share by Country in 2021
Figure 45. United States Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Aurora Kinase B Sales Market Share by Region in 2021
Figure 50. APAC Aurora Kinase B Revenue Market Share by Regions in 2021
Figure 51. China Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Aurora Kinase B Sales Market Share by Country in 2021
Figure 58. Europe Aurora Kinase B Revenue Market Share by Country in 2021
Figure 59. Germany Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Aurora Kinase B Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Aurora Kinase B Revenue Market Share by Country in 2021
Figure 66. Egypt Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Aurora Kinase B Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Aurora Kinase B in 2021
Figure 72. Manufacturing Process Analysis of Aurora Kinase B
Figure 73. Industry Chain Structure of Aurora Kinase B
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...